BCAB

NASDAQStock

BioAtla, Inc.

$0.17-0.00 (-0.86%)

52-Week Range

$0.14

$1.22

Key Stats

Market Cap

9.8M

P/E Ratio

—

Dividend Yield

—

Beta

1.08

Volume

821.9K

Avg Volume

1.6M

Performance

+12.20%

-78.21%

-76.69%

YTD

-68.49%

-53.31%

-93.45%

-99.75%

Price Chart

ETF Exposure

BCAB is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
STSB	iShares Factors US Small Blend Style ETF	0.12%	187	$7K	$7.3M	0.35%
XCHA.DE	Xtrackers CSI300 Swap UCITS ETF 1C	0.00%	379,196	$55K	$1.41B	0.50%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	58	$21	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,092	$762	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	10	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,191,032	$320K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,264	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	540	$196	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	458,220	$123K	$84.10B	0.05%
XWD1.F	Xtrackers MSCI World Swap UCITS ETF	0.00%	149,589	$22K	$2.17B	0.19%
XWD1.SG	Xtrackers MSCI World Swap UCITS ETF	0.00%	149,589	$22K	$9.68B	0.00%
XWEH.DE	Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged	0.00%	149,589	$22K	$9.60B	0.39%

About BCAB ETF Exposure

BioAtla, Inc. (BCAB) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 9.8M, BCAB is a widely held institutional stock. The stock currently trades at $0.17. Investors can gain exposure to BCAB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BCAB, sorted by portfolio weight.